Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb 5;32(4):284-287.
doi: 10.1055/s-0041-1741470. eCollection 2023 Dec.

A Renal Artery Stenting Case: Support for Increased Use of Drug-Eluting Stents

Achim Viertel  1 , Nils Breese  2 , Lars Krist  1 , Gerian Groenefeld  1
Affiliations
Case Reports

A Renal Artery Stenting Case: Support for Increased Use of Drug-Eluting Stents

Achim Viertel et al. Int J Angiol. .

Abstract

Fibromuscular dysplasia is a rare, systemic arteriovascular disease that often affects the renal arteries. Balloon angioplasty is recommended for uncontrolled hypertension and compromised renal function; stenting is a bailout option. Drug-eluting stents have been suggested in case reports. We report the successful intervention with an everolimus-coated stent in a very young patient. The patient was followed for 2 years after placing the stent. The success of this case suggests that drug-eluting stents should be used more frequently in comparable situations.

Keywords: antihypertensive therapy; drug-eluting stent; duplex ultrasound; fibromuscular dysplasia; percutaneous renal balloon angioplasty; renal artery stenosis; uncontrolled hypertension.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Figures

Fig. 1
Fig. 1
Duplex ultrasound of the right renal artery flow with a pathologic resistance index (RI) of 0.45 (*) and a velocity of >200 cm/s (**) before intervention.
Fig. 2
Fig. 2
Pre-interventional angiography showing focal stenosis of the right renal artery (↑) 179 × 120 mm (144 × 144 DPI).
Fig. 3
Fig. 3
Thrombotic occlusion (↑↑↑) of the distal part of the right renal artery after predilatation.
Fig. 4
Fig. 4
Restoration of complete reperfusion (↑↑↑) of the distal renal artery after stent (*) placement.
Fig. 5
Fig. 5
Duplex ultrasound of the right renal artery with a normal resistance index (RI) of 0.59 (*) 3 months after the intervention.
See this image and copyright information in PMC

References

    1. Edem E, Aksoy M N, Pabuccu M T, Tatlı E. Endovascular treatment of renal artery stenosis due to fibromuscular dysplasia—is stent implantation underused in this circumstance? Heart Views. 2016;17(02):69–71. - PMC - PubMed
    1. Herrmann S M, Textor S C. Current concepts in the treatment of renovascular hypertension. Am J Hypertens. 2018;31(02):139–149. - PMC - PubMed
    1. Gornik H L, Persu A, Adlam D et al.First international consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019;24(02):164–189. - PubMed
    1. ARCADIA Investigators . Plouin P F, Baguet J P, Thony F et al.High prevalance of multiple arterial bed lesions in patients with fibromuscular dysplasia. The ARCADIA Registry (assessment of renal and cervical artery dysplasia) Hypertension. 2017;70(03):652–658. - PubMed
    1. Davies M G, Saad W E, Peden E K, Mohiuddin I T, Naoum J J, Lumsden A B. The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg. 2008;48(04):865–871. - PubMed

Publication types

LinkOut - more resources